Kutki for Immune Function

Research suggests that Kutki (Picrorhiza kurroa) demonstrates immunomodulatory properties, with studies pointing to its active compounds, particularly picrosides and the standardized extract Picroliv, as potential mediators of immune activity. The available evidence includes in vitro work examining macrophage cytokine modulation, a 2016 cell-based study on rhizome extracts, and several reviews and monographs spanning 2001 to 2021 that consistently characterize immune modulation as one of the plant's notable pharmacological properties. All identified studies trend in a supportive direction, though the body of evidence relies heavily on reviews, monographs, and laboratory models rather than clinical trials in humans, which represents a meaningful limitation when assessing real-world applicability. Studies indicate this is an area of ongoing scientific interest, but well-designed human trials would be needed before firmer conclusions about immune-related effects in people could be drawn.